Cargando…

Evaluating the impact of the ICNET® clinical decision support system for antimicrobial stewardship

BACKGROUND: Antimicrobial resistance (AMR) is an ecological and economic crisis and stewardship of available antimicrobials is required. Electronic prescribing, where available, enables auditing of practice, yet in order to be efficient and effective in addressing inappropriate antimicrobial prescri...

Descripción completa

Detalles Bibliográficos
Autores principales: Heard, Katie L., Hughes, Stephen, Mughal, Nabeela, Azadian, Berge S., Moore, Luke S. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404285/
https://www.ncbi.nlm.nih.gov/pubmed/30886704
http://dx.doi.org/10.1186/s13756-019-0496-4
_version_ 1783400842984947712
author Heard, Katie L.
Hughes, Stephen
Mughal, Nabeela
Azadian, Berge S.
Moore, Luke S. P.
author_facet Heard, Katie L.
Hughes, Stephen
Mughal, Nabeela
Azadian, Berge S.
Moore, Luke S. P.
author_sort Heard, Katie L.
collection PubMed
description BACKGROUND: Antimicrobial resistance (AMR) is an ecological and economic crisis and stewardship of available antimicrobials is required. Electronic prescribing, where available, enables auditing of practice, yet in order to be efficient and effective in addressing inappropriate antimicrobial prescribing, better use of current and new technological interventions is needed. This retrospective observational evaluation looked at the impact of a commercial clinical decision support system (CDSS) on the workflow of an established antimicrobial stewardship (AMS) team. MATERIAL/METHODS: Clinical, workflow, and pharmaceutical data from 3 months post implementation of CDSS were collated, and compared to the same 3 month periods in preceding years. The evaluation considered total interventions made, the types of intervention made, impact of said interventions, and time spent executing interventions. All antimicrobial data were adjusted for total daily defined doses (DDD) of intravenous antimicrobials. RESULTS: Productivity: In the 3 month evaluation period (Jun-Aug 2016) a total of 264 case reviews resulting in 298 AMS interventions were made. Compared to preceding years where 138 and 169 interventions were made (2013 and 2014 respectively). In 2013 49% of interventions were stopping medication and 30% change of therapy based on cultures and sensitivities compared to 25 and 17% in 2016. In contrast to previous years’, the CDSS instead enabled a greater number of dose/drug optimisation (13%), escalation of antimicrobials (12%) and intravenous (IV) to oral switch (11%) interventions. Patient Identification: Despite increased patient numbers post-CDSS, on average 46 min per day was spent compiling a patient list for review, compared to 59 min in 2014. The use of CDSS facilitated 15 interventions/1000DDD, compared to pre-intervention (9.4/1000DDD in 2013; 11.5/1000DDD in 2014). CONCLUSIONS: Initial evaluation of the impact of this CDSS on AMS at the organisation has demonstrated effectiveness in terms of case finding, AMS team productivity, and workflow auditing. More importantly, patient infection management has been optimised with a shift in the emphasis of AMS interventions. It has contributed to the success of the healthcare provider achieving nationally set remunerated AMS targets.
format Online
Article
Text
id pubmed-6404285
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64042852019-03-18 Evaluating the impact of the ICNET® clinical decision support system for antimicrobial stewardship Heard, Katie L. Hughes, Stephen Mughal, Nabeela Azadian, Berge S. Moore, Luke S. P. Antimicrob Resist Infect Control Research BACKGROUND: Antimicrobial resistance (AMR) is an ecological and economic crisis and stewardship of available antimicrobials is required. Electronic prescribing, where available, enables auditing of practice, yet in order to be efficient and effective in addressing inappropriate antimicrobial prescribing, better use of current and new technological interventions is needed. This retrospective observational evaluation looked at the impact of a commercial clinical decision support system (CDSS) on the workflow of an established antimicrobial stewardship (AMS) team. MATERIAL/METHODS: Clinical, workflow, and pharmaceutical data from 3 months post implementation of CDSS were collated, and compared to the same 3 month periods in preceding years. The evaluation considered total interventions made, the types of intervention made, impact of said interventions, and time spent executing interventions. All antimicrobial data were adjusted for total daily defined doses (DDD) of intravenous antimicrobials. RESULTS: Productivity: In the 3 month evaluation period (Jun-Aug 2016) a total of 264 case reviews resulting in 298 AMS interventions were made. Compared to preceding years where 138 and 169 interventions were made (2013 and 2014 respectively). In 2013 49% of interventions were stopping medication and 30% change of therapy based on cultures and sensitivities compared to 25 and 17% in 2016. In contrast to previous years’, the CDSS instead enabled a greater number of dose/drug optimisation (13%), escalation of antimicrobials (12%) and intravenous (IV) to oral switch (11%) interventions. Patient Identification: Despite increased patient numbers post-CDSS, on average 46 min per day was spent compiling a patient list for review, compared to 59 min in 2014. The use of CDSS facilitated 15 interventions/1000DDD, compared to pre-intervention (9.4/1000DDD in 2013; 11.5/1000DDD in 2014). CONCLUSIONS: Initial evaluation of the impact of this CDSS on AMS at the organisation has demonstrated effectiveness in terms of case finding, AMS team productivity, and workflow auditing. More importantly, patient infection management has been optimised with a shift in the emphasis of AMS interventions. It has contributed to the success of the healthcare provider achieving nationally set remunerated AMS targets. BioMed Central 2019-03-06 /pmc/articles/PMC6404285/ /pubmed/30886704 http://dx.doi.org/10.1186/s13756-019-0496-4 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Heard, Katie L.
Hughes, Stephen
Mughal, Nabeela
Azadian, Berge S.
Moore, Luke S. P.
Evaluating the impact of the ICNET® clinical decision support system for antimicrobial stewardship
title Evaluating the impact of the ICNET® clinical decision support system for antimicrobial stewardship
title_full Evaluating the impact of the ICNET® clinical decision support system for antimicrobial stewardship
title_fullStr Evaluating the impact of the ICNET® clinical decision support system for antimicrobial stewardship
title_full_unstemmed Evaluating the impact of the ICNET® clinical decision support system for antimicrobial stewardship
title_short Evaluating the impact of the ICNET® clinical decision support system for antimicrobial stewardship
title_sort evaluating the impact of the icnet® clinical decision support system for antimicrobial stewardship
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404285/
https://www.ncbi.nlm.nih.gov/pubmed/30886704
http://dx.doi.org/10.1186/s13756-019-0496-4
work_keys_str_mv AT heardkatiel evaluatingtheimpactoftheicnetclinicaldecisionsupportsystemforantimicrobialstewardship
AT hughesstephen evaluatingtheimpactoftheicnetclinicaldecisionsupportsystemforantimicrobialstewardship
AT mughalnabeela evaluatingtheimpactoftheicnetclinicaldecisionsupportsystemforantimicrobialstewardship
AT azadianberges evaluatingtheimpactoftheicnetclinicaldecisionsupportsystemforantimicrobialstewardship
AT moorelukesp evaluatingtheimpactoftheicnetclinicaldecisionsupportsystemforantimicrobialstewardship